second generation zymoxins (Tel Aviv University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namesecond generation zymoxins (Tel Aviv University)
Drug Alias NameNS3 protease-activated chimeric toxins (Tel Aviv University)
ClassificationBiologics
Mechanisms of ActionHepatitis C virus (HCV) nonstructural protein 3 modulators
TargetsHepatitis C virus (HCV) nonstructural protein 3
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRamot At Tel Aviv UniversityTel Aviv University
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A